Evidence-based guidelines on the therapeutic use of repetitive transcranial magnetic stimulation (rTMS): An update (2014–2018)
André Aleman
1
,
D. Benninger
2
,
Jérome Brunelin
3
,
Vincenzo Di Lazzaro
4
,
S. Filipović
5
,
Christian Grefkes
6, 7
,
Alkomiet Hasan
8
,
Satu K. Jääskeläinen
9
,
Berthold Langguth
10
,
L. Leocani
11
,
Alain Londero
12
,
Jean-Paul Nguyen
13, 14
,
Antonio Oliviero
15
,
Frank Padberg
8
,
Ulrich Palm
16, 17
,
W J Paulus
18
,
A. Quartarone
19
,
Fady Rachid
20
,
SIMONE ROSSI
21
,
Hanna Sahlsten
22
,
Martin Schecklmann
10
,
David Szekely
23
,
Ulf Ziemann
24
3
11
12
13
Multidisciplinary Pain Center, Clinique Bretéché, ELSAN, Nantes, France
|
14
Multidisciplinary Pain, Palliative and Supportive Care Center, UIC22-CAT2-EA3826, University Hospital, CHU Nord-Laënnec, Nantes, France.
|
17
Medical Park Chiemseeblick, Bernau, Germany
|
18
20
Private practice, Geneva, Switzerland.
|
23
Department of Psychiatry, Princess Grace Hospital, Monaco.
|
Тип публикации: Journal Article
Дата публикации: 2020-02-01
scimago Q1
wos Q1
БС1
SJR: 1.329
CiteScore: 7.9
Impact factor: 3.6
ISSN: 13882457, 18728952
PubMed ID:
31901449
Neurology
Physiology (medical)
Neurology (clinical)
Sensory Systems
Краткое описание
A group of European experts reappraised the guidelines on the therapeutic efficacy of repetitive transcranial magnetic stimulation (rTMS) previously published in 2014 [Lefaucheur et al., Clin Neurophysiol 2014;125:2150-206]. These updated recommendations take into account all rTMS publications, including data prior to 2014, as well as currently reviewed literature until the end of 2018. Level A evidence (definite efficacy) was reached for: high-frequency (HF) rTMS of the primary motor cortex (M1) contralateral to the painful side for neuropathic pain; HF-rTMS of the left dorsolateral prefrontal cortex (DLPFC) using a figure-of-8 or a H1-coil for depression; low-frequency (LF) rTMS of contralesional M1 for hand motor recovery in the post-acute stage of stroke. Level B evidence (probable efficacy) was reached for: HF-rTMS of the left M1 or DLPFC for improving quality of life or pain, respectively, in fibromyalgia; HF-rTMS of bilateral M1 regions or the left DLPFC for improving motor impairment or depression, respectively, in Parkinson's disease; HF-rTMS of ipsilesional M1 for promoting motor recovery at the post-acute stage of stroke; intermittent theta burst stimulation targeted to the leg motor cortex for lower limb spasticity in multiple sclerosis; HF-rTMS of the right DLPFC in posttraumatic stress disorder; LF-rTMS of the right inferior frontal gyrus in chronic post-stroke non-fluent aphasia; LF-rTMS of the right DLPFC in depression; and bihemispheric stimulation of the DLPFC combining right-sided LF-rTMS (or continuous theta burst stimulation) and left-sided HF-rTMS (or intermittent theta burst stimulation) in depression. Level A/B evidence is not reached concerning efficacy of rTMS in any other condition. The current recommendations are based on the differences reached in therapeutic efficacy of real vs. sham rTMS protocols, replicated in a sufficient number of independent studies. This does not mean that the benefit produced by rTMS inevitably reaches a level of clinical relevance.
Найдено
Ничего не найдено, попробуйте изменить настройки фильтра.
Найдено
Ничего не найдено, попробуйте изменить настройки фильтра.
Топ-30
Журналы
|
10
20
30
40
50
60
|
|
|
Brain Sciences
60 публикаций, 3.67%
|
|
|
Frontiers in Neurology
56 публикаций, 3.43%
|
|
|
Brain Stimulation
46 публикаций, 2.82%
|
|
|
Frontiers in Psychiatry
36 публикаций, 2.2%
|
|
|
Clinical Neurophysiology
36 публикаций, 2.2%
|
|
|
Journal of Affective Disorders
29 публикаций, 1.77%
|
|
|
Frontiers in Neuroscience
27 публикаций, 1.65%
|
|
|
Frontiers in Human Neuroscience
25 публикаций, 1.53%
|
|
|
Journal of Clinical Medicine
21 публикация, 1.29%
|
|
|
Frontiers in Aging Neuroscience
18 публикаций, 1.1%
|
|
|
Neurological Sciences
17 публикаций, 1.04%
|
|
|
Neuromodulation
16 публикаций, 0.98%
|
|
|
Neurorehabilitation and Neural Repair
14 публикаций, 0.86%
|
|
|
BMJ Open
14 публикаций, 0.86%
|
|
|
Trials
13 публикаций, 0.8%
|
|
|
Scientific Reports
12 публикаций, 0.73%
|
|
|
Neurophysiologie Clinique
12 публикаций, 0.73%
|
|
|
Psychiatry Research
12 публикаций, 0.73%
|
|
|
BMC Neurology
11 публикаций, 0.67%
|
|
|
Journal of Psychiatric Research
11 публикаций, 0.67%
|
|
|
Brain and Behavior
11 публикаций, 0.67%
|
|
|
NeuroRehabilitation
10 публикаций, 0.61%
|
|
|
BMC Psychiatry
10 публикаций, 0.61%
|
|
|
International Journal of Molecular Sciences
9 публикаций, 0.55%
|
|
|
European Archives of Psychiatry and Clinical Neuroscience
9 публикаций, 0.55%
|
|
|
Neurotherapeutics
9 публикаций, 0.55%
|
|
|
Medicine (United States)
8 публикаций, 0.49%
|
|
|
Neuroscience Bulletin
8 публикаций, 0.49%
|
|
|
Journal of NeuroEngineering and Rehabilitation
8 публикаций, 0.49%
|
|
|
10
20
30
40
50
60
|
Издатели
|
50
100
150
200
250
300
350
400
450
|
|
|
Elsevier
437 публикаций, 26.74%
|
|
|
Springer Nature
262 публикации, 16.03%
|
|
|
Frontiers Media S.A.
201 публикация, 12.3%
|
|
|
MDPI
134 публикации, 8.2%
|
|
|
Wiley
100 публикаций, 6.12%
|
|
|
Cold Spring Harbor Laboratory
71 публикация, 4.35%
|
|
|
SAGE
64 публикации, 3.92%
|
|
|
Ovid Technologies (Wolters Kluwer Health)
49 публикаций, 3%
|
|
|
Taylor & Francis
46 публикаций, 2.82%
|
|
|
Oxford University Press
29 публикаций, 1.77%
|
|
|
BMJ
19 публикаций, 1.16%
|
|
|
Institute of Electrical and Electronics Engineers (IEEE)
16 публикаций, 0.98%
|
|
|
Cambridge University Press
10 публикаций, 0.61%
|
|
|
Hindawi Limited
10 публикаций, 0.61%
|
|
|
Public Library of Science (PLoS)
9 публикаций, 0.55%
|
|
|
Media Sphere Publishing House
9 публикаций, 0.55%
|
|
|
IMR Press
8 публикаций, 0.49%
|
|
|
Baishideng Publishing Group
7 публикаций, 0.43%
|
|
|
IOP Publishing
7 публикаций, 0.43%
|
|
|
Georg Thieme Verlag KG
7 публикаций, 0.43%
|
|
|
IOS Press
6 публикаций, 0.37%
|
|
|
American Psychiatric Association Publishing
5 публикаций, 0.31%
|
|
|
eLife Sciences Publications
5 публикаций, 0.31%
|
|
|
Medknow
5 публикаций, 0.31%
|
|
|
The Japanese Association of Rehabilitation Medicine
5 публикаций, 0.31%
|
|
|
American Physiological Society
4 публикации, 0.24%
|
|
|
American Association for the Advancement of Science (AAAS)
4 публикации, 0.24%
|
|
|
Edizioni Minerva Medica
4 публикации, 0.24%
|
|
|
50
100
150
200
250
300
350
400
450
|
- Мы не учитываем публикации, у которых нет DOI.
- Статистика публикаций обновляется еженедельно.
Вы ученый?
Создайте профиль, чтобы получать персональные рекомендации коллег, конференций и новых статей.
Метрики
1.6k
Всего цитирований:
1637
Цитирований c 2024:
779
(47.67%)
Цитировать
ГОСТ |
RIS |
BibTex |
MLA
Цитировать
ГОСТ
Скопировать
Lefaucheur J. et al. Evidence-based guidelines on the therapeutic use of repetitive transcranial magnetic stimulation (rTMS): An update (2014–2018) // Clinical Neurophysiology. 2020. Vol. 131. No. 2. pp. 474-528.
ГОСТ со всеми авторами (до 50)
Скопировать
Aleman A., Benninger D., Brunelin J., Di Lazzaro V., Filipović S., Grefkes C., Hasan A., Jääskeläinen S. K., Langguth B., Leocani L., Londero A., Nguyen J., Oliviero A., Padberg F., Palm U., Paulus W. J., Quartarone A., Rachid F., ROSSI S., Sahlsten H., Schecklmann M., Szekely D., Ziemann U. Evidence-based guidelines on the therapeutic use of repetitive transcranial magnetic stimulation (rTMS): An update (2014–2018) // Clinical Neurophysiology. 2020. Vol. 131. No. 2. pp. 474-528.
Цитировать
RIS
Скопировать
TY - JOUR
DO - 10.1016/j.clinph.2019.11.002
UR - https://doi.org/10.1016/j.clinph.2019.11.002
TI - Evidence-based guidelines on the therapeutic use of repetitive transcranial magnetic stimulation (rTMS): An update (2014–2018)
T2 - Clinical Neurophysiology
AU - Aleman, André
AU - Benninger, D.
AU - Brunelin, Jérome
AU - Di Lazzaro, Vincenzo
AU - Filipović, S.
AU - Grefkes, Christian
AU - Hasan, Alkomiet
AU - Jääskeläinen, Satu K.
AU - Langguth, Berthold
AU - Leocani, L.
AU - Londero, Alain
AU - Nguyen, Jean-Paul
AU - Oliviero, Antonio
AU - Padberg, Frank
AU - Palm, Ulrich
AU - Paulus, W J
AU - Quartarone, A.
AU - Rachid, Fady
AU - ROSSI, SIMONE
AU - Sahlsten, Hanna
AU - Schecklmann, Martin
AU - Szekely, David
AU - Ziemann, Ulf
PY - 2020
DA - 2020/02/01
PB - Elsevier
SP - 474-528
IS - 2
VL - 131
PMID - 31901449
SN - 1388-2457
SN - 1872-8952
ER -
Цитировать
BibTex (до 50 авторов)
Скопировать
@article{2020_Lefaucheur,
author = {André Aleman and D. Benninger and Jérome Brunelin and Vincenzo Di Lazzaro and S. Filipović and Christian Grefkes and Alkomiet Hasan and Satu K. Jääskeläinen and Berthold Langguth and L. Leocani and Alain Londero and Jean-Paul Nguyen and Antonio Oliviero and Frank Padberg and Ulrich Palm and W J Paulus and A. Quartarone and Fady Rachid and SIMONE ROSSI and Hanna Sahlsten and Martin Schecklmann and David Szekely and Ulf Ziemann},
title = {Evidence-based guidelines on the therapeutic use of repetitive transcranial magnetic stimulation (rTMS): An update (2014–2018)},
journal = {Clinical Neurophysiology},
year = {2020},
volume = {131},
publisher = {Elsevier},
month = {feb},
url = {https://doi.org/10.1016/j.clinph.2019.11.002},
number = {2},
pages = {474--528},
doi = {10.1016/j.clinph.2019.11.002}
}
Цитировать
MLA
Скопировать
Lefaucheur, Jean-Pascal, et al. “Evidence-based guidelines on the therapeutic use of repetitive transcranial magnetic stimulation (rTMS): An update (2014–2018).” Clinical Neurophysiology, vol. 131, no. 2, Feb. 2020, pp. 474-528. https://doi.org/10.1016/j.clinph.2019.11.002.